DRUGS FOR THE PREVENTION OF CORONARY-THROMBOSIS - FROM AN ANIMAL-MODEL TO CLINICAL-TRIALS

被引:21
作者
FOLTS, JD
机构
[1] Cardiology Section, Department of Medicine, University of Wisconsin Medical School, Madison, Wisconsin
关键词
ATHEROSCLEROTIC DISEASE; THROMBOTIC OCCLUSION; PLATELET AGGREGOMETRY; CYCLIC FLOW (FOLTS) MODEL;
D O I
10.1007/BF00878571
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Platelets contribute to the progression of atherosclerotic disease and also to partial or complete thrombotic occlusion of stenosed human coronary or cerebral arteries. Thus, there is considerable interest in being able to measure in vivo or ex vivo platelet function or level of activity. Currently, platelet activity and the platelet inhibitory effect of drugs can be assessed ex vivo or in vitro by platelet aggregometry. There is also an experimental animal model (the cyclic flow, or Felts, model) for studying the interactions of platelets with damaged and stenosed arterial walls. This model was first used to show that aspirin can prevent coronary thrombosis in stenosed canine coronary arteries and is fairly predictive in determining which drugs are likely to inhibit platelet activity in vivo. It is also useful in identifying which drugs may be beneficial in ameliorating unstable angina and preventing coronary thrombosis. Studies with this model predict that aspirin, sulfinpyrazone, the monoclonal antibody 7E3 to the platelet glycoprotein GpIIb-IIIa fibrinogen receptor, arginine-glycine-aspartic acid peptide mimetics, or clopidogrel (an analogue of ticlopidine) would inhibit platelet-mediated thrombosis in patients with coronary or cerebral artery stenosis. The model also predicts that heparin or dipyridamole alone would not prevent platelet-mediated arterial thrombosis. Finally, studies with the cyclic model suggest that while serotonin receptor blockers, alpha-adrenergic blockade, or infusions of prostacyclin (or its analogue, Iloprost) would inhibit platelet activity, the resulting hypotension would severely limit the clinical usefulness of these compounds.
引用
收藏
页码:31 / 43
页数:13
相关论文
共 101 条
  • [1] AMLODIPINE IN ELDERLY HYPERTENSIVE PATIENTS - PHARMACOKINETICS AND PHARMACODYNAMICS
    ABERNETHY, DR
    GUTKOWSKA, J
    LAMBERT, MD
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1988, 12 : S67 - S71
  • [2] AIKEN JW, 1981, J PHARMACOL EXP THER, V219, P299
  • [3] INTRAVENOUS ADMINISTRATION OF MONOCLONAL-ANTIBODY TO THE PLATELET GP IIB/IIIA RECEPTOR TO TREAT ABRUPT CLOSURE DURING CORONARY ANGIOPLASTY
    ANDERSON, HV
    REVANA, M
    ROSALES, O
    BRANNIGAN, L
    STUART, Y
    WEISMAN, H
    WILLERSON, JT
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1992, 69 (16) : 1373 - 1376
  • [4] [Anonymous], 1985, FDA Drug Bull, V15, P34
  • [5] CYCLIC BLOOD-FLOW VARIATIONS INDUCED BY PLATELET-ACTIVATING FACTOR IN STENOSED CANINE CORONARY-ARTERIES DESPITE INHIBITION OF THROMBOXANE SYNTHETASE, SEROTONIN RECEPTORS, AND ALPHA-ADRENERGIC RECEPTORS
    APPRILL, P
    SCHMITZ, JM
    CAMPBELL, WB
    TILTON, G
    ASHTON, J
    RAHEJA, S
    BUJA, LM
    WILLERSON, JT
    [J]. CIRCULATION, 1985, 72 (02) : 397 - 405
  • [6] PLATELET ACTIVATION BY CIRCULATING LEVELS OF HORMONES - A POSSIBLE LINK IN CORONARY HEART-DISEASE
    ARDLIE, NG
    CAMERON, HA
    GARRETT, J
    [J]. THROMBOSIS RESEARCH, 1984, 36 (04) : 315 - 322
  • [7] RANDOMIZED TRIAL OF PROSTACYCLIN INFUSION IN ACUTE MYOCARDIAL-INFARCTION
    ARMSTRONG, PW
    LANGEVIN, LM
    WATTS, DG
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1988, 61 (06) : 455 - 457
  • [8] SEROTONIN AS A MEDIATOR OF CYCLIC FLOW VARIATIONS IN STENOSED CANINE CORONARY-ARTERIES
    ASHTON, JH
    BENEDICT, CR
    FITZGERALD, C
    RAHEJA, S
    TAYLOR, A
    CAMPBELL, WB
    BUJA, LM
    WILLERSON, JT
    [J]. CIRCULATION, 1986, 73 (03) : 572 - 578
  • [9] BADIMON L, 1992, THROMBOSIS CARDIOVAS, V24, P287
  • [10] ANTIPLATELET TREATMENT WITH TICLOPIDINE IN UNSTABLE ANGINA - A CONTROLLED MULTICENTER CLINICAL-TRIAL
    BALSANO, F
    RIZZON, P
    VIOLI, F
    SCRUTINIO, D
    CIMMINIELLO, C
    AGUGLIA, F
    PASOTTI, C
    RUDELLI, G
    [J]. CIRCULATION, 1990, 82 (01) : 17 - 26